Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Other Non-Current Assets (2022 - 2023)

Historic Other Non-Current Assets for Lexeo Therapeutics (LXEO) over the last 2 years, with Q3 2023 value amounting to $3.3 million.

  • Lexeo Therapeutics' Other Non-Current Assets rose 9.23% to $3.3 million in Q3 2023 from the same period last year, while for Sep 2023 it was $3.3 million, marking a year-over-year increase of 9.23%. This contributed to the annual value of $3.3 million for FY2022, which is N/A changed from last year.
  • Lexeo Therapeutics' Other Non-Current Assets amounted to $3.3 million in Q3 2023, which was up 9.23% from $3.3 million recorded in Q4 2022.
  • In the past 5 years, Lexeo Therapeutics' Other Non-Current Assets ranged from a high of $3.3 million in Q4 2022 and a low of $3.2 million during Q3 2022